MustGrow Announces Investor Relations Agreement with Harbor Access
SASKATOON, Saskatchewan, Canada, September 12, 2023 – MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”) is pleased to announce the engagement of Harbor Access LLC (“Harbor Access”) to perform investor relations services and activities, as defined in accordance with the policies of the TSX Venture Exchange (“TSXV”) and applicable securities laws.
“In connection with recent Company announcements including our significant project expansion with Janssen PMP, it is timely to refresh our investor relations and communications efforts, ” said Corey Giasson, CEO of MustGrow. “We believe that having an investor relations firm with broad experience in both the Canadian and US markets can provide strong support in creating wider awareness and expanding our investor base.”
“We are delighted to be working with Corey and the MustGrow team to enable more investors to be familiar with this unique and compelling investment opportunity given the growing importance of securing the global food supply,” stated Jonathan Paterson, Founder of Harbor Access
Pursuant to the agreement with Harbor Access, the Company will pay a cash fee of USD$8,000 per month over an initital period of 12 months, subject to renewal. Harbor Access does not control any common shares in the Company.
———
About MustGrow
MustGrow is an agriculture biotech company developing organic biocontrol, soil amendment and biofertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply and help farmers feed the world. MustGrow and its leading global partners — Janssen PMP (pharmaceutical division of Johnson & Johnson), Bayer, Sumitomo Corporation, and Univar Solutions’ NexusBioAg — are developing mustard-based organic solutions to potentially replace harmful synthetic chemicals. Concurrently, with new formulations derived from food- grade mustard, the Company is pursuing the adoption and use of its technology in the soil amendment and biofertily markets. Over 150 independent tests have been completed, validating MustGrow’s safe and effective approach to crop and food protection and yield enhancements. Pending regulatory approval, MustGrow’s patented liquid products could be applied through injection, standard drip or spray equipment, improving functionality and performance features. Now a platform technology, MustGrow and its global partners are pursuing applications in several different industries from preplant soil treatment and weed control, to postharvest disease control and food preservation, to soil amendment and biofertility. MustGrow has approximately 50.1 million basic common shares issued and outstanding and 56.3 million shares fully diluted. For further details, please visit www.mustgrow.ca.
Contact Information
Corey Giasson
Director & CEO
Phone: +1-306-668-2652
info@mustgrow.ca
About Harbor Access
Harbor Access represents and dvises micro to mega cap companies. The Company has a measured approach to creating a capital markets communications program, which helps optimize their clients’ visibility. Harbor Access brings extensive global experience and professionalism to each client and customizes every solution to meet their clients’ goals.
For more information about Harbor Access, please visit www.harbor-access.com
Contact Information
Jonathan Paterson
Founder & Managing Partner
Phone: +1-475-477-9401
Jonathan.Paterson@Harbor-access.com
MustGrow Forward-Looking Statements
Certain statements included in this news release constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.
Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”. Examples of forward-looking statements in this news release include, among others, statements MustGrow makes regarding creating wider awareness and expanding its investor base.
Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include market receptivity to investor relations activities as well as those risks described in more detail in MustGrow’s Annual Information Form for the year ended December 31, 2022 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available at www.sedar.com. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.
This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States.
Neither the TSXV, nor their Regulation Services Provider (as that term is defined in the policies of the TSXV), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release.
© 2023 MustGrow Biologics Corp. All rights reserved.